Large Retroperitoneal Lymph Node Associated with VTE in Disseminated Germ Cell Tumors
the Cancer Therapy Advisor take:
Large retroperitoneal lymph node (RPLN) is associated with venous thromboembolism (VTE) in patients with disseminated germ cell tumors (GCTs), providing better accuracy than high-risk Khorana score in this group, according to a recent study published in the Journal of Clinical Oncology.
Amirrtha Srikanthan, MD, of the Princess Margaret Cancer Centre in Toronto and fellow researchers looked at a training cohort of 216 patients with disseminated GCT who were receiving first-line chemotherapy from January 2000 to December 2010, with large RPLN defined as more than 5 centimeters in diameter.
Comparing predictive models using large RPLN with high-risk Khorana score in order to determine risk of VTE, the researchers found that the former method showed higher discriminatory accuracy, with further validation in a London cohort.
Twenty-one patients developed VTE during chemotherapy, and it was associated with large RPLN, high-risk Khorana score, intermediate- to poor-risk disease, and hospitalization.
“Prophylactic anticoagulation may be considered in high-risk patients,” the authors concluded. “Results should be validated in larger, prospective studies.”
RPLN is associated with VTE in patients with disseminated germ cell tumors.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Bleeding Disorder Treatments: Hemophilia A
- Pazopanib Plus Cetuximab May Be Effective and Well-Tolerated in Head and Neck Cancer
- FDA Approves Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer
- Bleeding Disorder Treatments: Hemophilia B
- Aggressive Follow-Up Imaging in Breast Cancer Is Geography-Specific